title: Busting the billion-dollar myth: how to slash the cost of drug development.
authors: Amy
authors: A
authors: Maxmen
mesh_terms: D000349:Africa; D000655:Amodiaquine / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use; D001549:Benzamides / Q000191:economics / Q000627:therapeutic use; D001896:Boron Compounds / Q000191:economics / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic / Q000191:economics / Q000379:methods; D003299:Cooperative Behavior; D019049:Developed Countries / Q000191:economics; D003906:Developing Countries / Q000191:economics; D017277:Drug Approval; D004338:Drug Combinations; D016527:Drug Costs; D055808:Drug Discovery / Q000191:economics* / Q000379:methods* / Q000458:organization & administration; D004345:Drug Industry / Q000191:economics* / Q000379:methods* / Q000458:organization & administration; D058492:Drug Repositioning / Q000191:economics; D004352:Drug Resistance, Microbial / Q000187:drug effects; D005260:Female; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D058069:Neglected Diseases / Q000188:drug therapy; D017008:Negotiating; D009593:Nitroimidazoles / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D009939:Organizations, Nonprofit / Q000191:economics* / Q000458:organization & administration*; D018401:Sample Size; D014353:Trypanosomiasis, African / Q000188:drug therapy; D014944:World Health Organization
chemical_list: D000900:Anti-Bacterial Agents; D037621:Artemisinins; D001549:Benzamides; D001896:Boron Compounds; D004338:Drug Combinations; D009593:Nitroimidazoles; C557508:SCYX 7158; D000655:Amodiaquine; C038307:fexinidazole; C031327:artemisinin